Table 5.
Infection Rates After Ventriculostomy
Study | Type | Cases | Infections | Infection Rate | Procedure Location | Culture Frequency | |
---|---|---|---|---|---|---|---|
1 | Alleyne et al., 200034 | R | 308 | 12 | 3.9% | Not specified | Twice weekly |
2 | Arabi et al., 200535 | R | 84 | 12 | 14.3% | Multiple locations | Daily |
3 | Bota et al., 200536 | P | 638 | 58 | 9.1% | Operating Room | Daily |
4 | Hoefnagel et al., 200837 | R | 228 | 53 | 23.2% | Operating room | 3 times/week |
5 | Kaufmann et al., 200438 | P | 158 | 13 | 8.2% | Operating room | Daily |
6 | Khan et al., 199839 | R | 104 | 7 | 6.7% | Not specified | Not Specified |
7 | Kim et al., 199540 | R | 61 | 7 | 11.5% | Operating room | Daily |
8 | Lackner et al., 200819 | P/R | 39 | 11 | 28.2% | Operating room | Daily in treatment group; 3 times/week in control group |
9 | Leung et al., 200741 | R | 103 | 7 | 6.8% | Operating room | Not routine |
10 | Lyke et al., 2001l42 | P | 151 | 11 | 7.3% | Multiple locations | At & 2 days after EVD placement |
11 | Mayhall et al., 198443 | P | 172 | 16 | 9.3% | Multiple locations | Not Specified |
12 | Naff et al., 201115 | RCT | 48 | 4 | 8.3% | Intensive care unit | Daily |
13 | Park et al., 200431 | R | 595 | 51 | 8.6% | Multiple locations | Not routine |
14 | Pfisterer et al., 200344 | P | 130 | 21 | 16.2% | Intensive care unit | 3 times/week |
15 | Roitberg et al., 200120 | R | 103 | 1 | 1.0% | Intensive care unit | Daily |
16 | Smith et al., 197621 | R | 56 | 3 | 5.4% | Multiple locations | Not routine |
17 | Tse et al., 201045 | R | 319 | 15 | 4.7% | Operating room | Not specified |
18 | Zentner et al., 199546 | P | 226 | 8 | 3.5% | Not specified | Not specified |
19 | Patil et al., 201329 | R | 111 | 5 | 4.5% | Not specified | Not specified |
20 | Wang et al., 201330 | P | 45 | 6 | 13.3% | Not specified | Not Specified |
21 | Flint et al., 201347 | R | 262 | 15 | 5.7% | Intensive care unit | Only if concern for infection |
22 | Lajcak et al., 201348 | R | 403 | 29 | 7.1% | Operating room | Routine monitoring |
23 | Winkler et al., 201349 | RTC | 61 | 11 | 18% | Not Specified | Every third day |
24 | Camacho et al., 201350 | P | 194 | 12 | 6.2% | Operating room | Only if concern for infection |
25 | Kubilay et al., 201351 | P | 2928 | 41 | 1.4% | Not specified | Only if concern for infection |
26 | Keong et al., 201252 | RTC | 278 | 47 | 16.9% | Not specified | Routine daily monitoring |
27 | Lwin et al., 201253 | R | 234 | 8 | 3.4% | Not Specified | Only if concern for infection |
28 | Lemcke et al., 201254 | R | 95 | 10 | 11% | Operating room | Only if concern for infection |
29 | Pople et al., 201255 | RTC | 434 | 9 | 2.5% | Not specified | Day of EVD placement, 3 days post EVD placement, upon EVD removal and in between if CSF infection suspected |
30 | Park et al., 201156 | R | 250 | 29 | 11.6% | Not specified | Not specified |
31 | Rafiq et al., 201157 | P | 76 | 9 | 11.8% | Operating room | Only if concern for infection |
32 | Guyot et al., 199822 | R | 274 | 20 | 7.29 | Not specified | Not Specified |
33 | North et al., 198633 | R | 199 | 7 | 3.5% | Not specified | Only if concern for infection |
32 | CLEAR III (ongoing) | RTC | 250 | 11 | 3.6% | Not specified | Daily |
P, prospective; R, retrospective; RCT, randomized clinical trial